(AOF) – Eurazeo has finalized the sale of DORC (Dutch Ophthalmic Research Center) to Carl Zeiss Meditec AG, one of the world’s leading medical technology companies. The transaction materializes a gross return of 2.6 times cash-on-cash and a gross internal rate of return (IRR) of 24% on the initial investment, with approximately €386 million of gross proceeds returning to the balance sheet. of Eurazeo.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
